Skip to main content

Table 1 Incidence of symptoms in patients with RDEB

From: A systematic literature review of the disease burden in patients with recessive dystrophic epidermolysis bullosa

Symptom

%

n/N

Design, country

Blisters/lesions

Blisters at or within 1 week of birth

94

15/16

Registry analysis, Australia/NZ [35]

86

12/14

Registry analysis, UK [33]

70

7/10

Single-center, Saudi Arabia [16]

Oral lesions

Any oral lesions

100

35/35a

Multicenter, Spain [48]

92

33/35b

Multicenter, Spain [48]

89

8/9c

Registry analysis, UK [33]

79

22/28

Single-center, Japan [43]

Lingual lesions

77

27/35

Multicenter, Spain [48]

Dental lesions

61

17/28

Single-center, Japan [43]

Soft palate lesions

60

21/35

Multicenter, Spain [48]

Oral bullae

59

10/17d

Case-review, Serbia [21]

Lesions on lips, mouth, tongue or ear

53

32/60

Single-center, Brazil [22]

Hard palate lesions

53

18/35

Multicenter, Spain [48]

Labial lesions

46

16/35

Multicenter, Spain [48]

Palatal milium cysts

46

16/35

Multicenter, Spain [48]

Jugal mucosa

34

12/35

Multicenter, Spain [48]

Other lesions

Nail lesions

75

21/28

Single-center, Japan [43]

Lip lesions

53

32/60

Single-center, Brazil [22]

Esophageal lesions

47

28/60

Single-center, Brazil [22]

Nostril lesions

18

11/60

Single-center, Brazil [22]

Eyelid blisters

7

5/72

Single-center, UK [51]

External ear canal lesions

3

2/60

Single-center, Brazil [22]

Larynx lesions

2

1/60

Single-center, Brazil [22]

Strictures/stenoses

Esophageal strictures/stenosis

86

6/7

Single-center, US [52]

81

43/53

Survey, US [53]

65

37/57

Single-center, UK [31]

64

100/157

Single-center, Germany [55]

64

53/83

Survey, International [54]

51

216/424

Registry analysis, US [30]

Other strictures/stenoses

Anal strictures

15

62/422

Registry analysis, US [30]

Pulmonary artery stenosis

14

1/7

Single-center, US [52]

Nostril stenoses

5

3/60

Single-center, Brazil [22]

Urethral meatal stenoses

3

14/425

Registry analysis, US [27]

Anterior commissure stenoses

2

1/60

Single-center, Brazil [22]

Pyloric stenoses or atresia

1

5/419

Registry analysis, US [30]

Laryngeal stenoses

0.7

3/412

Registry analysis, US [29]

Rectal strictures

0.2

1/422

Registry analysis, US [30]

Malnutrition/failure to thrive

Malnutrition/nutritional problems

72

38/53

Survey, US [53]

50

12/24

Single-center, France [20]

Failure to thrive

39

22/57

Single-center, UK [31]

25

21/83

Survey, International [54]

Growth problems diagnosed by physician

34

18/53

Survey, US [53]

Negative height standard deviation scores

94

17/18

Single-center, UK [44]

Negative height velocity standard deviation scores

89

16/18

Single-center, UK [44]

Nutritional deficiencies

Selenium deficiency

94

NR

Single-center, Germany [55]

Vitamin D deficiency

67

NR

Single-center, Germany [55]

Low albumin levels

56

NR

Single-center, Germany [55]

Zinc deficiency

55

NR

Single-center, Germany [55]

Anemia

Any anemia

100

10/10

Single-center, Saudi Arabia [16]

91

143/157

Single-center, Germany [55]

76

40/53

Survey, US [53]

68

17/25

Registry, Australia [34]

60

47/79

Registry, UK [17]

52

43/83

Survey, International [54]

50

3/6

Single-center, US [52]

Pseudosyndactyly

Any pseudosyndactyly

71

5/7

Single-center, Japan [43]

50

14/28

Single-center, US [52]

22

2/9

Single-center, Saudi Arabia [16]

Pseudosyndactyly of foot

55

46/83

Survey, International [54]

Pseudosyndactyly of hand

65

NR/425

Registry, US [28]

13

11/83

Survey, International [54]

Ocular symptoms

Any ocular symptoms

68

36/53

Survey, US [53]

52

16/31

NR, Chile [42]

52

43/83

Survey, International [54]

51

37/72

Single-center, UK [51]

Corneal complications in those with ocular symptoms

100

16/16

NR, Chile [42]

68

25/37

Single-center, UK [51]

63

5/8c

Registry analysis, UK [33]

Other ocular symptoms in those experiencing ocular involvement

Anterior blepharitis and collarettes

94

15/16

NR, Chile [42]

Corneal erosions

63

5/8c

Registry analysis, UK [33]

Symblepharon

59

8/16

NR, Chile [42]

Ectropion

38

6/16

NR, Chile [42]

13

1/8c

Registry analysis, UK [33]

Conjunctival complications

14

5/37

Single-center, UK [51]

Exposure keratitis associated with upper and lower eyelid extropian’s

8

3/37

Single-center, UK [51]

Other commonly reported symptoms

Nail dystrophy and loss

100

10/10

Single-center, Saudi Arabia [16]

100

12/12

Registry analysis, UK [33]

Milia

100

9/9

Single-center, Saudi Arabia [16]

93

49/53

Survey, US [53]

21

6/28

Single-center, Japan [43]

Constipation

75

9/12

Registry, UK [33]

72

38/53

Survey, US [53]

60

254/422

Registry analysis, US [30]

40

23/57

Single-center, UK [31]

Musculoskeletal contractures

87

46/53

Survey, US [53]

67

4/6

Single-center, US [52]

30

3/10

Single-center, Saudi Arabia [16]

Dental caries

24

54/225e

Case-review, Serbia [21]

Infections

Any infection

64

53/83

Survey, International [54]

Skin infection

90

9/10

Single-center, Saudi Arabia [16]

Recurrent respiratory infection

50

5/10

Single-center, Saudi Arabia [16]

Bacterial septicemia

20

2/10

Single-center, Saudi Arabia [16]

Candida septicemia

10

1/10

Single-center, Saudi Arabia [16]

  1. DEB, dystrophic epidermolysis bullosa; NR, not reported; NZ, New Zealand; RDEB, recessive dystrophic epidermolysis bullosa; UK, United Kingdom; US, United States
  2. aFibrotic lesion
  3. bBlister lesion
  4. cPopulation was patients with severe RDEB
  5. dPopulation was children with DEB (88% RDEB)
  6. eOf 225 permanent teeth in patients with RDEB